Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 153
10
Diseases
359
Unique genes
0.029
Avg. similarity score
Bone fracture
Most-connected disease (6 links)
Disease
Searched: Autosomal recessive osteopetrosis 5
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Autosomal recessive osteopetrosis 5
Bone fracture
Bone disease
Dupuytren contracture
Osteoporosis
Marbach-schaaf neurodevelopmental syndrome
Temtamy preaxial brachydactyly syndrome
Amyotrophic lateral sclerosis type 18
Parkinsonism with polyneuropathy
Succinyl-coa:3-oxoacid coa transferase deficiency
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Bone fracture | 6 | 6 | 68 |
| Bone disease | 4 | 4 | 83 |
| Dupuytren contracture | 4 | 4 | 89 |
| Osteoporosis | 4 | 4 | 161 |
| Marbach-schaaf neurodevelopmental syndrome | 2 | 2 | 1 |
| Temtamy preaxial brachydactyly syndrome | 2 | 2 | 1 |
| Amyotrophic lateral sclerosis type 18 | 1 | 1 | 1 |
| Autosomal recessive osteopetrosis 5 | 1 | 1 | 1 |
| Parkinsonism with polyneuropathy | 1 | 1 | 1 |
| Succinyl-coa:3-oxoacid coa transferase deficiency | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| SFRP4 | 4 / 10 | Bone disease, Bone fracture, Dupuytren contracture, Osteoporosis |
| STARD3NL | 4 / 10 | Bone disease, Bone fracture, Dupuytren contracture, Osteoporosis |
| AXIN1 | 3 / 10 | Bone disease, Bone fracture, Osteoporosis |
| CCDC170 | 3 / 10 | Bone disease, Bone fracture, Osteoporosis |
| CHSY1 | 3 / 10 | Bone fracture, Dupuytren contracture, Temtamy preaxial brachydactyly syndrome |
| CYP19A1 | 3 / 10 | Bone disease, Bone fracture, Osteoporosis |
| ESR1 | 3 / 10 | Bone disease, Bone fracture, Osteoporosis |
| FMN2 | 3 / 10 | Bone disease, Bone fracture, Dupuytren contracture |
| PRKAR1B | 3 / 10 | Bone fracture, Dupuytren contracture, Marbach-schaaf neurodevelopmental syndrome |
| RSPO3 | 3 / 10 | Bone disease, Bone fracture, Osteoporosis |
| SEM1 | 3 / 10 | Bone disease, Bone fracture, Osteoporosis |
| ZBTB40 | 3 / 10 | Bone disease, Dupuytren contracture, Osteoporosis |
| ALDH7A1 | 2 / 10 | Bone disease, Osteoporosis |
| AQP1 | 2 / 10 | Bone fracture, Osteoporosis |
| BMP2 | 2 / 10 | Bone disease, Osteoporosis |
| DDN | 2 / 10 | Bone disease, Osteoporosis |
| DOK6 | 2 / 10 | Bone fracture, Osteoporosis |
| FAM3C | 2 / 10 | Bone disease, Osteoporosis |
| HLA-DQA1 | 2 / 10 | Bone disease, Osteoporosis |
| HLA-DRB1 | 2 / 10 | Bone disease, Osteoporosis |
| JAG1 | 2 / 10 | Bone disease, Dupuytren contracture |
| LEPR | 2 / 10 | Bone disease, Osteoporosis |
| LRP5 | 2 / 10 | Bone fracture, Osteoporosis |
| OSTM1 | 2 / 10 | Autosomal recessive osteopetrosis 5, Osteoporosis |
| OXCT1 | 2 / 10 | Osteoporosis, Succinyl-coa:3-oxoacid coa transferase deficiency |
| PFN1 | 2 / 10 | Amyotrophic lateral sclerosis type 18, Bone disease |
| PPP6R3 | 2 / 10 | Bone disease, Osteoporosis |
| PTH | 2 / 10 | Bone disease, Osteoporosis |
| RAB31 | 2 / 10 | Bone fracture, Dupuytren contracture |
| SOX6 | 2 / 10 | Bone fracture, Osteoporosis |
| SUPT3H | 2 / 10 | Bone disease, Bone fracture |
| UQCRC1 | 2 / 10 | Bone fracture, Parkinsonism with polyneuropathy |
| WNT1 | 2 / 10 | Bone disease, Osteoporosis |
| WNT16 | 2 / 10 | Bone fracture, Osteoporosis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Proteoglycans in cancer | KEGG | 27 / 204 | 4.4× | 7.40e-11 | 9.01e-9 ✓ sig. |
| Wnt signaling pathway | KEGG | 21 / 174 | 4.0× | 5.22e-8 | 3.16e-6 ✓ sig. |
| Pathways in cancer | KEGG | 40 / 533 | 2.5× | 7.05e-8 | 4.11e-6 ✓ sig. |
| Breast cancer | KEGG | 19 / 148 | 4.3× | 8.45e-8 | 4.82e-6 ✓ sig. |
| p130Cas linkage to MAPK signaling for integrins | Reactome | 7 / 15 | 15.6× | 1.05e-7 | 5.85e-6 ✓ sig. |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | Reactome | 7 / 15 | 15.6× | 1.05e-7 | 5.85e-6 ✓ sig. |
| Integrin signaling | Reactome | 8 / 23 | 11.6× | 1.95e-7 | 1.00e-5 ✓ sig. |
| Platelet degranulation | Reactome | 16 / 123 | 4.4× | 7.50e-7 | 3.25e-5 ✓ sig. |
| Hepatocellular carcinoma | KEGG | 19 / 170 | 3.7× | 7.59e-7 | 3.28e-5 ✓ sig. |
| Basal cell carcinoma | KEGG | 11 / 63 | 5.8× | 2.23e-6 | 8.28e-5 ✓ sig. |
| Inflammatory bowel disease | KEGG | 11 / 66 | 5.6× | 3.59e-6 | 1.25e-4 ✓ sig. |
| Cushing syndrome | KEGG | 17 / 155 | 3.7× | 3.78e-6 | 1.30e-4 ✓ sig. |
| Hippo signaling pathway | KEGG | 17 / 157 | 3.6× | 4.50e-6 | 1.51e-4 ✓ sig. |
| Rheumatoid arthritis | KEGG | 13 / 95 | 4.6× | 4.66e-6 | 1.55e-4 ✓ sig. |
| Fluid shear stress and atherosclerosis | KEGG | 16 / 141 | 3.8× | 4.68e-6 | 1.56e-4 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| skeletal system development | GO:0001501 | 25 / 151 | 8.6× | 1.39e-16 | 1.33e-13 ✓ sig. |
| ossification | GO:0001503 | 22 / 110 | 10.4× | 1.49e-16 | 1.42e-13 ✓ sig. |
| osteoblast differentiation | GO:0001649 | 23 / 137 | 8.7× | 1.72e-15 | 1.36e-12 ✓ sig. |
| positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | GO:0051897 | 27 / 217 | 6.5× | 1.29e-14 | 8.66e-12 ✓ sig. |
| canonical Wnt signaling pathway | GO:0060070 | 19 / 105 | 9.4× | 1.24e-13 | 7.02e-11 ✓ sig. |
| positive regulation of ERK1 and ERK2 cascade | GO:0070374 | 25 / 201 | 6.5× | 1.28e-13 | 7.22e-11 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 63 / 1,208 | 2.7× | 3.08e-13 | 1.62e-10 ✓ sig. |
| positive regulation of osteoblast differentiation | GO:0045669 | 15 / 78 | 10.0× | 1.95e-11 | 6.94e-9 ✓ sig. |
| bone mineralization | GO:0030282 | 13 / 56 | 12.1× | 3.51e-11 | 1.19e-8 ✓ sig. |
| response to activity | GO:0014823 | 12 / 52 | 12.0× | 2.18e-10 | 6.14e-8 ✓ sig. |
| positive regulation of gene expression | GO:0010628 | 34 / 504 | 3.5× | 2.28e-10 | 6.39e-8 ✓ sig. |
| positive regulation of cell population proliferation | GO:0008284 | 35 / 532 | 3.4× | 2.40e-10 | 6.72e-8 ✓ sig. |
| bone morphogenesis | GO:0060349 | 10 / 32 | 16.3× | 2.68e-10 | 7.39e-8 ✓ sig. |
| cellular response to retinoic acid | GO:0071300 | 13 / 69 | 9.8× | 5.73e-10 | 1.44e-7 ✓ sig. |
| osteoclast differentiation | GO:0030316 | 11 / 49 | 11.7× | 1.71e-9 | 3.71e-7 ✓ sig. |